Allumia Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Affect Therapeutics operates an app-based digital treatment provider offering care for substance use disorders (alcohol, cannabis, opioid) and mental health conditions like depression and anxiety, using methods such as contingency management, CBT, medication-assisted treatment, and peer support.
Digital HealthHealthtechMental HealthNew York, US
Jeff DeFlavio(Co-founder)inKristin Muhlner(Executive Officer, Director)in
BoardKevin Ryan(Director)Jeff Rinehart(Director)in
Co-investorsArtis VenturesCity LightAlleyCorpLifeArc VenturesSamsung NextWhat If Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.